WESTERN BIG PHARMA IS IN SHOCK: US and EU oncology (cancer) drugs reached $176 billion in sales in 2021, more than double that of the next item on the list, vaccines with 88.6 billion dollars in sales.

By 2026, cancer drug sales are expected to almost double to $320.6 billion. Big Pharma rakes in up to 90% profit on expensive cancer treatments.

How important is cancer to Western Big Pharma? Imagine the effect if a fuel was discovered that on one charge could cheaply power a vehicle for its entire life.

Russia announces that within three years a vaccine that staves off and cures cancer will be available. Although every sanction imaginable would be applied to keep the lifesaving vaccine in Russia and out of the Western nations doing so would be problematic.

Russian medical researchers could be able to roll out oncological vaccines within the next couple of years, given adequate funding and support from lawmakers, a high-ranking official at the Federal Medical-Biological Agency (FMBA) said on Thursday. Most remaining obstacles to the vaccine appear to be regulatory, according to Vasily Lazarev of Russia’s Federal Medical-Biological Agency.

The comments come after President Vladimir Putin said last month that the country was one step away from developing vaccines against cancer.

‘If financial support is provided, I think that in two- or three years existing organizations will be able to put oncology vaccines into practice,’ Vasily Lazarev, deputy director of the Lopukhin Federal Scientific and Clinical Center for Physical and Chemical Medicine, told the outlet RTVI.

Domestic private investors will also be attracted to the technology ’after regulatory pressure eases,’ he added.

Lazarev did not bring up any medical or technological challenges, choosing instead to highlight the legal constraints facing vaccine development. 

‘I don’t know how quickly by-laws will be developed, it could take a year to resolve all the regulatory issues,’ he said. ’We have the tools, the production facilities, I think it’s not difficult to organize.’

Amendments proposed by the FMBA, which would allow for the production and use of variable composition medication, will go into effect in September. They also require the drugs to be produced at the same institution that holds the patent, however.

‘Organizing such production at home (local health centers) will be quite expensive, although it is feasible,’ Lazarev said. ’Most likely, these will be regional centers and maybe specialized oncological institutions.’

There are currently only a handful of facilities that could handle the production requirements, such as the Blokhin Cancer Center or the FMBA’s Federal Center for Brain and Neurotechnology, both located in Moscow.

Variable-composition neoantigens, which vaccine developers have focused on, don’t quite fit the current Russian legal framework and could not be used in treatments at all until very recently.

Putin revealed the development of cancer vaccines at the Future Technologies Forum in Moscow last month. The Russian president mentioned them among the developing medical technologies that he described as approaching science fiction.

Russian President Putin hinted at ‘science fiction’-level achievement at an event in Moscow. Speaking about the state of Russian medical science at the Future Technologies Forum in Moscow, Putin pointed out that enormous strides have been made in the early detection and treatment of cancer, leading to higher survival rates.

‘I will also add that we have come close to creating so-called onco-vaccines, vaccines against cancer, and immunomodulatory drugs of a new generation. And I hope that soon they will be effectively used as methods of individual therapy,’ he said. 

According to the president, more than half of all cancer cases in Russia are detected in the early stages, where the prognosis is the most favorable. He also pledged to continue funding medical research and development at the necessary levels.

‘Even just a little while ago, we could only read about such things in the works of fantasy fiction, but today all of this is becoming reality. All these areas are now just gaining momentum, and are expected to produce a real revolution in medicine shortly,’ he said.

One of the inventions is a special chip that can restore a person’s sight if implanted into the brain. The technology is currently undergoing clinical trials.

Advances in the field of medicine, prevention and treatment are valuable in and of themselves, but they require the participation of other fields of industry to be fully utilized by the Russian society, Putin said.

Therefore, Moscow views these key areas of industry as projects of national importance and is looking to build the entire industrial process – from the foundations and applications to the production and training of highly qualified workers – as an integrated chain.

PROFESSIONAL AND AFFORDABLE WRITING SERVICES for writers, businesses and publishers of periodicals. CLICK LINK. https://writingservicesandtranslations.wordpress.com/